Chlamydia Screening in Women
Compare Versions of: "Chlamydia Screening in Women"
The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.
Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.
Compare version to
| Measure Information | 2024 Performance Period | 2025 Performance Period | 2026 Performance Period | 2027 Performance Period |
|---|---|---|---|---|
| Title | Chlamydia Screening in Women | Chlamydia Screening in Women | Chlamydia Screening in Women | Chlamydia Screening in Women |
| CMS eCQM ID | CMS153v12 | CMS153v13 | CMS153v14 | CMS153v15 |
| CBE ID* | Not Applicable | Not Applicable | Not Applicable | Not Applicable |
| MIPS Quality ID | 310 | 310 | 310 | 310 |
| Measure Steward | National Committee for Quality Assurance | National Committee for Quality Assurance | National Committee for Quality Assurance | National Committee for Quality Assurance |
| Description |
Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during the measurement period |
Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during the measurement period |
Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during the measurement period |
Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during the measurement period |
| Measure Scoring | Proportion | Proportion | Proportion | Proportion |
| Measure Type | Process | Process | Process | Process |
| Stratification |
Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period Stratum 2: Patients age 21-24 by the end of the measurement period |
Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period. Stratum 2: Patients age 21-24 by the end of the measurement period. |
Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period. Stratum 2: Patients age 21-24 by the end of the measurement period. |
Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period. Stratum 2: Patients age 21-24 by the end of the measurement period. |
| Risk Adjustment |
None |
None |
None |
None |
| Rationale |
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in roughly 1.7 million cases (Centers for Disease Control and Prevention, 2019). Chlamydia infections are often asymptomatic, but, if left untreated, can lead to serious and irreversible complications (U.S. Preventive Services Task Force, 2014; Centers for Disease Control and Prevention, 2019). Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), which can lead to chronic pelvic pain or infertility. Pregnant women may also transmit the infection to their infant, potentially resulting in neonatal pneumonia (Centers for Disease Control and Prevention, 2019). |
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in roughly 1.7 million cases (Centers for Disease Control and Prevention, 2019). Chlamydia infections are often asymptomatic, but, if left untreated, can lead to serious and irreversible complications (U.S. Preventive Services Task Force, 2021; Centers for Disease Control and Prevention, 2019). Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), which can lead to chronic pelvic pain or infertility. Pregnant women may also transmit the infection to their infant, potentially resulting in neonatal pneumonia (Centers for Disease Control and Prevention, 2019). |
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in roughly 1.7 million cases (Centers for Disease Control and Prevention, 2019). Chlamydia infections are often asymptomatic, but, if left untreated, can lead to serious and irreversible complications (U.S. Preventive Services Task Force, 2021; Centers for Disease Control and Prevention, 2019). Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), which can lead to chronic pelvic pain or infertility. Pregnant women may also transmit the infection to their infant, potentially resulting in neonatal pneumonia (Centers for Disease Control and Prevention, 2019). |
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in roughly 1.7 million cases (Centers for Disease Control and Prevention, 2019). Chlamydia infections are often asymptomatic, but, if left untreated, can lead to serious and irreversible complications (U.S. Preventive Services Task Force, 2021; Centers for Disease Control and Prevention, 2019). Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), which can lead to chronic pelvic pain or infertility. Pregnant women may also transmit the infection to their infant, potentially resulting in neonatal pneumonia (Centers for Disease Control and Prevention, 2019). |
| Clinical Recommendation Statement |
U.S. Preventive Services Task Force (2021) recommends screening for chlamydia in all sexually active women aged 24 years or younger and in women 25 years or older who are at increased risk for infection (B recommendation) |
U.S. Preventive Services Task Force (2021) recommends screening for chlamydia in all sexually active women aged 24 years or younger and in women 25 years or older who are at increased risk for infection (B recommendation) |
U.S. Preventive Services Task Force (2021) recommends screening for chlamydia in all sexually active women aged 24 years or younger and in women 25 years or older who are at increased risk for infection (B recommendation) |
U.S. Preventive Services Task Force (2021) recommends screening for chlamydia in all sexually active women aged 24 years or younger and in women 25 years or older who are at increased risk for infection (B recommendation) |
| Improvement Notation |
Higher score indicates better quality |
Higher score indicates better quality |
Higher score indicates better quality |
Higher score indicates better quality |
| Definition |
None |
None |
None |
None |
| Guidance |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
| Initial Population |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
| Denominator |
Equals Initial Population |
Equals Initial Population |
Equals Initial Population |
Equals Initial Population |
| Denominator Exclusions |
Women who are only eligible for the initial population due to a pregnancy test during the measurement period, and who had an order for an x-ray or for a specified medication on the date of the pregnancy test or the six days after the pregnancy test. Exclude patients who are in hospice care for any part of the measurement period. |
Exclude patients who are in hospice care for any part of the measurement period. Women who are only eligible for the initial population due to a pregnancy test during the measurement period, and who had an order for an x-ray or for a specified medication on the date of the pregnancy test or the six days after the pregnancy test. |
Exclude patients who are in hospice care for any part of the measurement period. Women who are only eligible for the initial population due to a pregnancy test during the measurement period, and who had an order for an x-ray or for a specified medication on the date of the pregnancy test or the six days after the pregnancy test. |
Exclude patients who are in hospice care for any part of the measurement period. Women who are only eligible for the initial population due to a pregnancy test during the measurement period, and who had an order for an x-ray or for a specified medication on the date of the pregnancy test or the six days after the pregnancy test. |
| Numerator |
Women with at least one chlamydia test during the measurement period |
Women with at least one chlamydia test during the measurement period |
Women with at least one chlamydia test during the measurement period |
Women with at least one chlamydia test during the measurement period |
| Numerator Exclusions |
Not Applicable |
Not Applicable |
None |
None |
| Denominator Exceptions |
None |
None |
None |
None |
| Telehealth Eligible | Yes | Yes | Yes | Yes |
| Next Version | No Version Available | |||
| Previous Version | No Version Available |
Additional Resources for CMS153v15
Header
| TRN | Measure Section | Source of Change |
|---|---|---|
Updated the eCQM version number. | eCQM Version Number | Annual Update |
Updated the measurement period from 'January 1, 2026 through December 31, 2026' to 'January 1, 2027 through December 31, 2027.' | Measurement Period | Annual Update |
Updated copyright. | Copyright | Annual Update |
Value Set
The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.
| TRN | Measure Section | Source of Change |
|---|---|---|
Value Set 'Contraceptive Medications' (2.16.840.1.113883.3.464.1003.196.12.1080): Added 1 RxNorm code (2716396) based on SME/Expert recommendations. Deleted 1 RxNorm code (602598) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Diagnostic Studies During Pregnancy' (2.16.840.1.113883.3.464.1003.111.12.1008): Added 2 LOINC codes (100875-4, 100876-2) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Encounter Inpatient' (2.16.840.1.113883.3.666.5.307): Added 4 SNOMEDCT codes (112689000, 15584006, 442281000124108, 81672003) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Lab Tests During Pregnancy' (2.16.840.1.113883.3.464.1003.111.12.1007): Added 1 LOINC code (111004-8) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Lab Tests for Sexually Transmitted Infections' (2.16.840.1.113883.3.464.1003.110.12.1051): Added 31 LOINC codes (103182-2, 103183-0, 104170-6, 104752-1, 104765-3, 104766-1, 104780-2, 104783-6, 105077-2, 105085-5, 105193-7, 106051-6, 106508-5, 106509-3, 106936-8, 106996-2, 106997-0, 106998-8, 106999-6, 107000-2, 107001-0, 107002-8, 107003-6, 107004-4, 107005-1, 107006-9, 107007-7, 107369-1, 107460-8, 107461-6, 111382-8) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Office Visit' (2.16.840.1.113883.3.464.1003.101.12.1001): Added 8 CPT codes (98000, 98001, 98002, 98003, 98004, 98005, 98006, 98007) based on SME/Expert recommendations. Added 2 SNOMEDCT codes (30346009, 37894004) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Pap Test' (2.16.840.1.113883.3.464.1003.108.12.1017): Added 1 LOINC code (104866-9) based on SME/Expert recommendations. Deleted 1 LOINC code (19764-0) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Payer Type' (2.16.840.1.114222.4.11.3591): Deleted 42 SOPT codes (111, 1112, 3111, 3112, 3114, 3115, 3116, 3119, 3121, 3122, 3211, 3212, 32121, 32122, 32123, 32124, 32125, 32126, 32127, 32128, 3222, 3223, 3229, 3711, 3712, 3713, 3811, 3812, 3813, 3819, 6, 61, 611, 612, 613, 614, 619, 62, 621, 622, 623, 629) based on new or changed coding guidance. | Terminology | Annual Update |
Value Set 'Telephone Visits' (2.16.840.1.113883.3.464.1003.101.12.1080): Added 6 CPT codes (98979, 98980, 98981, 99457, 99458, 99470) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'Virtual Encounter' (2.16.840.1.113883.3.464.1003.101.12.1089): Added 1 CPT code (98016) based on SME/Expert recommendations. Deleted 4 CPT codes (98980, 98981, 99457, 99458) based on SME/Expert recommendations. | Terminology | Annual Update |
Value Set 'XRay Study' (2.16.840.1.113883.3.464.1003.198.12.1034): Added 447 LOINC codes (100655-0, 100760-8, 100881-2, 100882-0, 100883-8, 100884-6, 101301-0, 103228-3, 103229-1, 103230-9, 103231-7, 103232-5, 103233-3, 103234-1, 103235-8, 103236-6, 103237-4, 103238-2, 103239-0, 103240-8, 103241-6, 103242-4, 103243-2, 103244-0, 103245-7, 103246-5, 103247-3, 103248-1, 103249-9, 103250-7, 103251-5, 103252-3, 103253-1, 103254-9, 103255-6, 103256-4, 103257-2, 103258-0, 103259-8, 103260-6, 103261-4, 103262-2, 103263-0, 103264-8, 103265-5, 103266-3, 103267-1, 103268-9, 103269-7, 103270-5, 103271-3, 103272-1, 103273-9, 103274-7, 103276-2, 103277-0, 103278-8, 103279-6, 103280-4, 103282-0, 103283-8, 103285-3, 103286-1, 103287-9, 103288-7, 103290-3, 103291-1, 103292-9, 103293-7, 103294-5, 103295-2, 103296-0, 103297-8, 103298-6, 103299-4, 103300-0, 103301-8, 103302-6, 103303-4, 103304-2, 103305-9, 103306-7, 103307-5, 103308-3, 103309-1, 103310-9, 103311-7, 103312-5, 103313-3, 103314-1, 103315-8, 103316-6, 103317-4, 103318-2, 103319-0, 103320-8, 103321-6, 103322-4, 103323-2, 103324-0, 103325-7, 103326-5, 103327-3, 103328-1, 103329-9, 103331-5, 103332-3, 103333-1, 103334-9, 103335-6, 103336-4, 103337-2, 103338-0, 103339-8, 103340-6, 103341-4, 103342-2, 103343-0, 103344-8, 103345-5, 103346-3, 103348-9, 103349-7, 103350-5, 103351-3, 103352-1, 103353-9, 103354-7, 103355-4, 103356-2, 103359-6, 103360-4, 103361-2, 103364-6, 103365-3, 103367-9, 103368-7, 103369-5, 103370-3, 103371-1, 103372-9, 103373-7, 103374-5, 103375-2, 103377-8, 103378-6, 103379-4, 103380-2, 103381-0, 103384-4, 103388-5, 103390-1, 103391-9, 103392-7, 103393-5, 103394-3, 103395-0, 103396-8, 103397-6, 103399-2, 103400-8, 103401-6, 103402-4, 103403-2, 103404-0, 103405-7, 103406-5, 103407-3, 103408-1, 103413-1, 103416-4, 103418-0, 103419-8, 103420-6, 103423-0, 103424-8, 103427-1, 103428-9, 103431-3, 103432-1, 103433-9, 103435-4, 103436-2, 103437-0, 103438-8, 103439-6, 103441-2, 103442-0, 103443-8, 103444-6, 103445-3, 103446-1, 103448-7, 103449-5, 103450-3, 103451-1, 103453-7, 103454-5, 103455-2, 103457-8, 103460-2, 103461-0, 103462-8, 103463-6, 103466-9, 103467-7, 103468-5, 103469-3, 103470-1, 103471-9, 103472-7, 103473-5, 103474-3, 103475-0, 103476-8, 103477-6, 103478-4, 103479-2, 103481-8, 103482-6, 103485-9, 103488-3, 103490-9, 103491-7, 103493-3, 103495-8, 103496-6, 103498-2, 103499-0, 103500-5, 103501-3, 103502-1, 103504-7, 103506-2, 103508-8, 103513-8, 103515-3, 103519-5, 103520-3, 103521-1, 103522-9, 103523-7, 103524-5, 103525-2, 103526-0, 103527-8, 103529-4, 103531-0, 103533-6, 103534-4, 103535-1, 103536-9, 103537-7, 103539-3, 103541-9, 103848-8, 103849-6, 103850-4, 103851-2, 103859-5, 103860-3, 103861-1, 103862-9, 103863-7, 103864-5, 103865-2, 103866-0, 103867-8, 103868-6, 103869-4, 103870-2, 103871-0, 103872-8, 103873-6, 103874-4, 103875-1, 103876-9, 103877-7, 103878-5, 103879-3, 103880-1, 103881-9, 103882-7, 103883-5, 103884-3, 103944-5, 103945-2, 104128-4, 104129-2, 104130-0, 104131-8, 104869-3, 104870-1, 104937-8, 104939-4, 104940-2, 104941-0, 104942-8, 104943-6, 104944-4, 104945-1, 104946-9, 105128-3, 105129-1, 105130-9, 105131-7, 105132-5, 105133-3, 105134-1, 105135-8, 105136-6, 105137-4, 105138-2, 105139-0, 105140-8, 105141-6, 105142-4, 105143-2, 105144-0, 105145-7, 105146-5, 105147-3, 105148-1, 105149-9, 105150-7, 105151-5, 105152-3, 105153-1, 105154-9, 105155-6, 105156-4, 105157-2, 105158-0, 105159-8, 105160-6, 105161-4, 105162-2, 105163-0, 105164-8, 105165-5, 105166-3, 105167-1, 105168-9, 105169-7, 105170-5, 105171-3, 105172-1, 105173-9, 105174-7, 106814-7, 106815-4, 106816-2, 106817-0, 106818-8, 106820-4, 106821-2, 106823-8, 106824-6, 106825-3, 106826-1, 106828-7, 106837-8, 106844-4, 106845-1, 106847-7, 106848-5, 106849-3, 106850-1, 106851-9, 106852-7, 106853-5, 106854-3, 106856-8, 106857-6, 107258-6, 107259-4, 107262-8, 107263-6, 107264-4, 107265-1, 107266-9, 107267-7, 107268-5, 107273-5, 107274-3, 107276-8, 107278-4, 107290-9, 107291-7, 107292-5, 107294-1, 107295-8, 107296-6, 107297-4, 107298-2, 107299-0, 107301-4, 107302-2, 107303-0, 107304-8, 107305-5, 107306-3, 107307-1, 107386-5, 107387-3, 107388-1, 107390-7, 107391-5, 107393-1, 107403-8, 107405-3, 107406-1, 107408-7, 107409-5, 107410-3, 107411-1, 107412-9, 107424-4, 107437-6, 107439-2, 107440-0, 107441-8, 107442-6, 108348-4, 98897-2, 98898-0, 98899-8, 98900-4, 99505-0, 99506-8, 99507-6, 99508-4, 99509-2, 99510-0, 99608-2, 99609-0, 99610-8, 99611-6, 99612-4, 99613-2, 99628-0, 99629-8, 99630-6, 99702-3, 99703-1, 99704-9, 99705-6) based on SME/Expert recommendations. Deleted 50 LOINC codes (24655-3, 24808-8, 24927-6, 24928-4, 24986-2, 24987-0, 25041-5, 25042-3, 26361-6, 26362-4, 26363-2, 28566-8, 28613-8, 30629-0, 30713-2, 35933-1, 35936-4, 36067-7, 36256-6, 36399-4, 36400-0, 36530-4, 36531-2, 36934-8, 36935-5, 37427-2, 37572-5, 37875-2, 37876-0, 37877-8, 37878-6, 37879-4, 39052-6, 39070-8, 39322-3, 41795-6, 42383-0, 42442-4, 42688-2, 42689-0, 42690-8, 44102-2, 44194-9, 44222-8, 44238-4, 46281-2, 47985-7, 48442-8, 48748-8, 87906-4) based on SME/Expert recommendations. | Terminology | Annual Update |